- Abstract Number: 1000
Obesity and Foot Problems in the Framingham Foot Study: Does Foot Structure or Foot Function Protect Against Hallux Valgus?
- Abstract Number: 1699
Obesity and Pediatric Psoriatic Arthritis
- Abstract Number: 1598
Obesity and the Risk for Development of Rheumatoid Arthritis – Results from a Population-Based Nested Case-Control Study
- Abstract Number: 1703
Obesity Is Related with Active State in Psoriatic Arthritis and Rheumatoid Arthritis but Not Ankylosing Spondylitis at Real Life Biological Cohort
- Abstract Number: 1112
Obinutuzumab Outperforms Rituximab at Inducing B-Cell Cytotoxicity in Vitro through Fc-Mediated Effector Mechanisms in Rheumatoid Arthritis and Systemic Lupus Erythematosus
- Abstract Number: 1697
Obstructive Sleep Apnea and Fatigue in Inflammatory Arthritis Patients Taking TNF-Inhibitors
- Abstract Number: 839
Occupational Exposures in Patients with Systemic Sclerosis Associated with Increased Frequency of Interstitial Lung Disease and Primary Pulmonary Hypertension
- Abstract Number: 2246
Occupations Involving Manual Labor Increase the Risk for Incident Knee Osteoarthritis
- Abstract Number: 1567
Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting
- Abstract Number: 1532
Occurrence of Valvular Heart Disease in Rheumatoid Arthritis: A Population Based Study
- Abstract Number: 3063
Ocular Findings and Ocular Blood Flow Changes in Takayasu Arteritis: A Subclinical Reduction in Blood Flow with a Milder Clinical Course of Retinopathy
- Abstract Number: 500
Ofatumumab for Rheumatoid Arthritis: A Cochrane Systematic Review and Meta-Analysis
- Abstract Number: 326
Older Adults without Extreme Obesity Are at Highest Risk for Accelerated Knee Osteoarthritis
- Abstract Number: 2021
Omega-3 Fatty Acids Are Associated with a Lower Prevalence of Autoantibody Positivity in HLA-DR Shared Epitope Positive Subjects Who Are at Increased Risk for Future RA
- Abstract Number: 554
On Drug and Drug-Free Remission By Baseline Disease Duration: Abatacept Versus Methotrexate Comparison in Patients with Early Rheumatoid Arthritis
- Abstract Number: 477
On-Demand Use of Etanercept Only for Disease Flares Reduced the Disease Activity Score and Structural Damage Equivalent to Fully-Use of Etanercept in RA Patients
- Abstract Number: 1914
Oncostatin M As a Potential Molecular Target in Systemic Sclerosis
- Abstract Number: 139
One-Year Cost of Etanercept, Adalimumab, and Infliximab per Treated Patient with Chronic Inflammatory Arthritides in US Veterans
- Abstract Number: 144
One-Year Costs Following Switching Versus Dose-Escalation Among Prevalent Tumor Necrosis Factor Inhibitors Used for Rheumatoid Arthritis
- Abstract Number: 1672
One-Year Safety of Sirukumab Monotherapy: Results from a Randomized, Double-Blind, Parallel-Group, Multicenter Study in Japanese Subjects with Moderate to Severe Rheumatoid Arthritis
- Abstract Number: 1295
Online Consultation for Rheumatic Disease Patients Based on Smart System of Disease Management (SSDM) Mobile Tools: A Study of Medical Economics
- Abstract Number: 1230
Only One-Third of Patients with Spondyloarthritis Are Managed By Rheumatologists
- Abstract Number: 1792
Optimal Monitoring for Coronary Heart Disease Risk in Systemic Lupus Erythematosus Patients: a Systematic Review
- Abstract Number: 581
Optimization of Treatment Intervals of Tocilizumab and Golimumab By Measuring Serum Trough Levels in Rheumatoid Arthritis Patients
- Abstract Number: 1220
Oral Glucocorticoid Prescribing Patterns in UK Primary Care for Patients with Rheumatoid Arthritis
- Abstract Number: 51
Oral Glucocorticoid Use Is Associated with Osteonecrosis in Adults with Chronic Inflammatory Diseases but Not in Children: A Population-Based Cohort Study
- Abstract Number: 1438
Oral Potassium (K+) Reduces Pain in RA: A Randomized Active Control Study of Diet Based K+ Intervention
- Abstract Number: 3194
Oral to Subcutaneous Methotrexate Dose-Conversion Strategies in the Treatment of Rheumatoid Arthritis
- Abstract Number: 723
Oral Ulcers in Systemic Lupus Erythematosus: Characterization and Clarification of an Important Clinical Manifestation
- Abstract Number: 783
Osteonecrosis in Systemic Lupus Erythematosus: Predictive Factors
- Abstract Number: 1702
Osteoporosis in Psoriatic Arthritis
- Abstract Number: 380
Osteoporosis Screening and Treatment of Rheumatoid Arthritis Patients at a Teaching Institution
- Abstract Number: 378
Osteoporotic Fragility Tibia/Fibula Fractures Are Not Asociated with a Low Body Mass Index: An Observational Study
- Abstract Number: 1825
Osteoprotegerin Is Associated with Lupus and with Coronary Artery Calcification
- Abstract Number: 2930
Outcome of Patients with Systemic Lupus Erythematous (SLE) after Thrombotic Events
- Abstract Number: 3070
Outcome of Pregnancies in Patients with Takayasu Arteritis with Special Focus on Risk Factors and Disease Activity
- Abstract Number: 585
Outcomes after Discontinuing Tumor Necrosis Factor Inhibitor in Rheumatoid Arthritis: 2 Years of ‘post-Golimumab’ after Completion of the 5-Year Extension Study in Korea
- Abstract Number: 1440
Outcomes and Cost-Effectiveness of Shoulder Injections with Sonographic Needle Guidance
- Abstract Number: 555
Outcomes Associated with Non-Medical Switching/Discontinuation of Anti-TNF Inhibitors Among Patients with Rheumatoid Arthritis
- Abstract Number: 2941
Outcomes in Lupus Nephritis Patients Previously Randomized to Receive Either Low Dose Cyclophosphamide Versus Oral Mycophenolate Mofetil on Azathioprine Maintenance
- Abstract Number: 2510
Outpatient Consultation Requests: A Failure to Communicate
- Abstract Number: 3012
Over-Expression of Ubiquitin-Specific Peptidases in Systemic Sclerosis Fibroblasts Increases Responses to TGF-Beta
- Abstract Number: 2178
Oxidation of beta2-Glycoprotein I (beta2-GPI) Associates with the Presence of Antibodies to Domain I of beta2-GPI in Patients with the Antiphospholipid Syndrome but Is Not Affected By the Antibodies in Vivo in a Rat Model
- Abstract Number: 1780
Oxidative Stress Protects Against Nephritis Induced By Chronic Graft Versus Host Disease
2015 ACR/ARHP Annual Meeting
November 6-11, 2015. San Francisco, CA.